GATM

Chr 15ARAD

glycine amidinotransferase

Also known as: AGAT, AT, CCDS3, FRTS, FRTS1, RFS

This gene encodes a mitochondrial enzyme that belongs to the amidinotransferase family. This enzyme is involved in creatine biosynthesis, whereby it catalyzes the transfer of a guanido group from L-arginine to glycine, resulting in guanidinoacetic acid, the immediate precursor of creatine. Mutations in this gene cause arginine:glycine amidinotransferase deficiency, an inborn error of creatine synthesis characterized by cognitive disability, language impairment, and behavioral disorders. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAR/ADLOEUF 0.532 OMIM phenotypes
VCEP Guidelines: Cerebral Creatine DeficiencyReleased
View SpecificationsClinGen Panel
Clinical SummaryGATM
🧬
Gene-Disease Validity (ClinGen)
AGAT deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.28) despite low pLI — interpret in context.
📋
ClinVar Variants
39 unique Pathogenic / Likely Pathogenic· 302 VUS of 669 total submissions
📖
GeneReview available — GATM
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.53LOEUF
pLI 0.051
Z-score 3.29
OE 0.28 (0.160.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.29Z-score
OE missense 0.59 (0.510.68)
144 obs / 244.8 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.28 (0.160.53)
00.351.4
Missense OE?0.59 (0.510.68)
00.61.4
Synonymous OE?0.91
01.21.6
LoF obs/exp: 7 / 24.6Missense obs/exp: 144 / 244.8Syn Z: 0.61
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGATM-related arginine:glycine amidinotransferase deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6356th %ile
GOF
0.4875th %ile
LOF
0.3746th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

669 submitted variants in ClinVar

Classification Summary

Pathogenic18
Likely Pathogenic21
VUS302
Likely Benign283
Benign37
Conflicting6
18
Pathogenic
21
Likely Pathogenic
302
VUS
283
Likely Benign
37
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
16
1
1
0
18
Likely Pathogenic
13
8
0
0
21
VUS
4
262
28
8
302
Likely Benign
0
4
132
147
283
Benign
0
3
30
4
37
Conflicting
6
Total33278191159667

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

11 pathogenic / likely-pathogenic (of 27) ClinVar copy-number / structural variants overlap GATM — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GATM · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →